Metrics as of 10/14/2026, 08:40 AM (Berlin time), refresh in progress.
Manhattan Bridge Capital, Inc.
Manhattan Bridge Capital, Inc. (MBC) functions as a dedicated real estate financing firm, actively originating, servicing, and overseeing a diverse portfolio of first-position mortgage loans across the United States. The company extends short-duration, collateral-backed, non-traditional financing solutions to real…
1D
+1.8%
1W
-7.1%
1M
-15.4%
6M
-26.4%
YTD
-26.9%
1Y
-36.2%
2Y
-37.4%
5Y
-45.3%
10Y
-54.1%
Next earnings date
23/10/2026 (in 6 days)
Volatility around earnings
~43% weaker price swings than usual
0
STRONG BUY
2
BUY
1
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 16/03/2023
P/E
8.09
P/B
0.9
EV/EBITDA
12.19
RETURN ON EQUITY
2.7%
NET MARGIN
56.4%
DEBT/EQUITY
0.45
DIVIDEND YIELD
13.1%
AS OF
30/06/2026
FREE FLOAT
75.3%
FLOAT SHARES
8,605,789
AVG. DAILY VOLUME (30D)
41,829
RAN ASSAF
Manhattan Bridge Capital, Inc. is a company in the Real Estate sector, REIT - Mortgage industry, headquartered in United States.
The CEO is Assaf Ran, the company employs around 6 people.
The IPO was on 13/05/1999; the stock trades on NASDAQ under the ticker LOAN.
3 analysts rate the stock, the consensus is Buy (as of 16/03/2023).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 23/10/2026.
Around past earnings, price swings were roughly -43% stronger than usual.
Yes. The last dividend was US$0.11 per share, ex-date 08/10/2026, paid on 15/10/2026.
The dividend yield is 13.1% (as of 30/06/2026).
Comparable stocks include Orchid Island Capital, Welltower, Prologis, Equinix, American Tower, Digital Realty Trust, Simon Property Group and Public Storage.
Clicking "Analyze stock" lets five strategies assess Manhattan Bridge Capital against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.